Thrombin receptor expression is upregulated in prostate cancer.

Prostate

Department of Internal Medicine, University of Arkansas for Medical Sciences, and Division of Hematology/Oncology, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205, USA.

Published: February 2006

Background: Aberrant expression of protease-activated receptors (PARs) has been associated with increased angiogenesis, tumor growth, and metastasis of various cancers. We assessed the status of PAR1 expression in prostate cancer.

Methods: The study compared the abundance levels of PAR1 RNA and protein using real-time reverse-transcriptase polymerase chain reaction and immunoblotting in freshly resected prostate tissues from early localized-stage disease (n=9) to those from patients with advanced metastatic disease (n=7). PAR1 expression and localization was evaluated using immunohistochemical staining of prostate specimens with benign prostatic hyperplasia (n=27), early- (n=32) and advanced-stage (n=22) prostate cancer. Association analyses of PAR1 expression with expression of VEGF-family of growth factors, their receptors, and clinicopathological characteristics of the patients were also performed.

Results: PAR1 RNA expression in advanced-stage prostate was 2.39-fold higher (P=0.024) and its protein expression was 2.75-fold higher (P=5.89x10(-5)) when compared with early-stage prostate cancer. PAR1 expression was localized to endothelial cells in vascular network of prostate tumor areas. The expression of PAR1 correlated statistically significantly with advanced disease stage (P=0.0006) and pre-operative PSA levels (P=0.005) in these samples.

Conclusions: These findings demonstrate that PAR1 expression is increased in prostate cancer. Its predominant expression in vascular network suggests that it may play a direct and crucial role in angiogenesis and could be a relevant target for therapeutic interventions to control or to prevent disease progression.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20326DOI Listing

Publication Analysis

Top Keywords

par1 expression
20
prostate cancer
16
expression
12
prostate
9
par1
8
par1 rna
8
vascular network
8
thrombin receptor
4
receptor expression
4
expression upregulated
4

Similar Publications

Plant architecture greatly contributes to grain yield, but the epigenetic regulation of plant architecture remains elusive. Here, we identified the maize (Zea mays L.) mutant plant architecture 1 (par1), which shows reduced plant height, shorter and narrower leaves, and larger leaf angles than the wild type.

View Article and Find Full Text PDF

USP34 regulates endothelial PAR1 mRNA transcript expression and cellular signaling.

Mol Biol Cell

December 2024

Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA, 92093.

Signaling by G protein-coupled receptors (GPCRs) is regulated by temporally distinct processes including receptor desensitization, internalization, and lysosomal sorting, and are tightly controlled by post-translational modifications. While the role of phosphorylation in regulating GPCR signaling is well studied and established, the mechanisms by which other post-translational modifications, such as ubiquitination, regulate GPCR signaling are not clearly defined. We hypothesize that GPCR ubiquitination and deubiquitination is critical for proper signaling and cellular responses.

View Article and Find Full Text PDF

Lung cancer is a fatal complication of idiopathic pulmonary fibrosis (IPF) with a poor prognosis. Current treatments are insufficient in improving the prognosis of lung cancer patients with comorbid idiopathic pulmonary fibrosis (IPF-LC). Senescent fibroblasts, as stromal cells in the tumor microenvironment, influence tumor progression via exosomes.

View Article and Find Full Text PDF

The association between idiopathic venous thrombosis and occult cancer is widely recognized. However, the comprehensive understanding of how thrombin, generated during the process of thrombosis, possesses the potential to augment the malignant phenotype is still not well understood. The coagulation protease thrombin mediates its effects by cleaving protease-activated receptor 1 (PAR1), a receptor abundantly expressed on the surface of triple-negative breast cancer (TNBC) cells.

View Article and Find Full Text PDF

Human Pulmonary Neuroendocrine Cells Respond to House Dust Mite Extract With PAR-1 Dependent Release of CGRP.

Allergy

November 2024

Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, and Alberta Respiratory Centre, University of Alberta, Edmonton, Alberta, Canada.

Article Synopsis
  • - The study focuses on pulmonary neuroendocrine cells (PNEC), which are important yet rare cells in the airway that may influence allergic asthma, and introduces a new in vitro model to study their functions in response to allergens like house dust mite (HDM).
  • - Researchers created PNEC cultures from human stem cells and primary bronchial cells, exposing them to various stimuli (HDM, Bergamot oil, and LPS) to measure changes in gene expression and neuropeptide release.
  • - Findings showed that HDM specifically triggered an increase in the CALCB gene and the release of the neuropeptide CGRP, highlighting PNEC's role in the neuroendocrine response to allergens, which can
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!